Sedentary time and markers of chronic low-grade inflammation in a high risk population

Joseph Henson, Thomas Yates, Charlotte L Edwardson, Kamlesh Khunti, Duncan Talbot, Laura J Gray, Thomas M Leigh, Patrice Carter, Melanie J Davies, Joseph Henson, Thomas Yates, Charlotte L Edwardson, Kamlesh Khunti, Duncan Talbot, Laura J Gray, Thomas M Leigh, Patrice Carter, Melanie J Davies

Abstract

Background: Sedentary behaviour has been identified as a distinct risk factor for several health outcomes. Nevertheless, little research has been conducted into the underlying mechanisms driving these observations. This study aimed to investigate the association of objectively measured sedentary time and breaks in sedentary time with markers of chronic low-grade inflammation and adiposity in a population at a high risk of type 2 diabetes mellitus.

Methods: This study reports data from an ongoing diabetes prevention programme conducted in Leicestershire, UK. High risk individuals were recruited from 10 primary care practices. Sedentary time (<25 counts per 15 s) was measured using Actigraph GT3X accelerometers (15 s epochs). A break was considered as any interruption in sedentary time (≥25 counts per 15 s). Biochemical outcomes included interleukin-6 (IL-6), C-reactive protein (CRP), leptin, adiponectin and leptin:adiponectin ratio (LAR). A sensitivity analysis investigated whether results were affected by removing participants with a CRP level >10 mg/L, as this can be indicative of acute inflammation.

Results: 558 participants (age = 63.6±7.7 years; male = 64.7%) had complete adipokine and accelerometer data. Following adjustment for various confounders, sedentary time was detrimentally associated with CRP (β = 0.176±0.057, p = 0.002), IL-6 (β = 0.242±0.056, p = <0.001), leptin (β = 0.146±0.043, p = <0.001) and LAR (β = 0.208±0.052, p = <0.001). Associations were attenuated after further adjustment for moderate-to-vigorous physical activity (MVPA) with only IL-6 (β = 0.231±0.073, p = 0.002) remaining significant; this result was unaffected after further adjustment for body mass index and glycosylated haemoglobin (HbA1c). Similarly, breaks in sedentary time were significantly inversely associated with IL-6 (β = -0.094±0.047, p = 0.045) and leptin (β = -0.075±0.037, p = 0.039); however, these associations were attenuated after adjustment for accelerometer derived variables. Excluding individuals with a CRP level >10 mg/L consistently attenuated the significant associations across all markers of inflammation.

Conclusion: These novel findings from a high risk population recruited through primary care suggest that sedentary behaviour may influence markers associated with inflammation, independent of MVPA, glycaemia and adiposity.

Conflict of interest statement

Competing Interests: DT has an affiliation to the commercial funder of this research; Unilever Discover, UK (employee). Furthermore, MJD and KK are members of the National Institute for Health and Clinical Excellence Public Health Guidance on the prevention of type 2 diabetes. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

References

    1. Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nat Rev Endocrinol 8: 457–465.
    1. Wang X, Bao W, Liu J, Ouyang YY, Wang D, et al. (2013) Inflammatory markers and risk of type 2 diabetes: A systematic review and meta-analysis. Diabetes Care 36: 166–175.
    1. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840–846.
    1. Tsigos C, Papanicolaou DA, Kyrou I, Defensor R, Mitsiadis CS, et al. (1997) Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 82: 4167–4170.
    1. Trayhurn P, Wood IS (2004) Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92: 347–355.
    1. Franks PW, Farooqi IS, Luan J, Wong MY, Halsall I, et al. (2003) Does physical activity energy expenditure explain the between-individual variation in plasma leptin concentrations after adjusting for differences in body composition? J Clin Endocrinol Metab 88: 3258–3263.
    1. Ertek S, Cicero A (2012) Impact of physical activity on inflammation: Effects on cardiovascular disease risk and other inflammatory conditions. Arch Med Sci 8: 794–804.
    1. Nader GA, Lundberg IE (2009) Exercise as an anti-inflammatory intervention to combat inflammatory diseases of muscle. Curr Opin Rheumatol 21: 599–603.
    1. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, et al. (2011) The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 11: 607–615.
    1. Kasapis C, Thompson PD (2005) The effects of physical activity on serum C-reactive protein and inflammatory markers: A systematic review. J Am Coll Cardiol 45: 1563–1569.
    1. Panagiotakos DB, Pitsavos C, Chrysohoou C, Kavouras S, Stefanadis C, et al. (2005) The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardiovascular disease: The ATTICA study. Prev Med 40: 432–437.
    1. Henson J, Yates T, Biddle SJ, Edwardson CL, Khunti K, et al. (2013) Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia 56: 1012–1020.
    1. Edwardson CL, Gorely T, Davies MJ, Gray LJ, Khunti K, et al. (2012) Association of sedentary behaviour with metabolic syndrome: A meta-analysis. PLoS One 7: e34916.
    1. Thorp AA, Owen N, Neuhaus M, Dunstan DW (2011) Sedentary behaviors and subsequent health outcomes in adults a systematic review of longitudinal studies, 1996–2011. Am J Prev Med 41: 207–215.
    1. Wilmot EG, Edwardson CL, Achana FA, Davies MJ, Gorely T, et al. (2012) Sedentary time in adults and the association with diabetes, cardiovascular disease and death: Systematic review and meta-analysis. Diabetologia 55: 2895–2905.
    1. Healy GN, Matthews CE, Dunstan DW, Winkler EA, Owen N (2011) Sedentary time and cardio-metabolic biomarkers in US adults: NHANES 2003-06. Eur Heart J 32: 590–597.
    1. Allison MA, Jensky NE, Marshall SJ, Bertoni AG, Cushman M (2012) Sedentary behavior and adiposity-associated inflammation: The multi-ethnic study of atherosclerosis. Am J Prev Med 42: 8–13.
    1. Yates T, Khunti K, Wilmot EG, Brady E, Webb D, et al. (2012) Self-reported sitting time and markers of inflammation, insulin resistance, and adiposity. Am J Prev Med 42: 1–7.
    1. Neilson HK, Robson PJ, Friedenreich CM, Csizmadi I (2008) Estimating activity energy expenditure: How valid are physical activity questionnaires? Am J Clin Nutr 87: 279–291.
    1. Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41: 1241–1248.
    1. Tataranni PA, Ortega E (2005) A burning question: Does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes 54: 917–927.
    1. Lago R, Gomez R, Lago F, Gomez-Reino J, Gualillo O (2008) Leptin beyond body weight regulation—current concepts concerning its role in immune function and inflammation. Cell Immunol 252: 139–145.
    1. Yates T, Davies MJ, Henson J, Troughton J, Edwardson C, et al. (2012) Walking away from type 2 diabetes: Trial protocol of a cluster randomized controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetes. BMC Fam Pract 13: 46.
    1. Gray LJ, Davies MJ, Hiles S, Taub NA, Webb DR, et al. (2012) Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia 55: 959–966.
    1. Freedson PS, Melanson E, Sirard J (1998) Calibration of the computer science and applications, inc. accelerometer. Med Sci Sports Exerc 30: 777–781.
    1. Healy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, et al. (2008) Breaks in sedentary time: Beneficial associations with metabolic risk. Diabetes Care 31: 661–666.
    1. Trost SG, McIver KL, Pate RR (2005) Conducting accelerometer-based activity assessments in field-based research. Med Sci Sports Exerc 37: S531–43.
    1. The English Indices of Deprivation 2007 Summary. Available: . Accessed 2013 July 19.
    1. World Health Organization 2006: Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Available: . Accessed 2013 July 19.
    1. Finucane FM, Luan J, Wareham NJ, Sharp SJ, O'Rahilly S, et al. (2009) Correlation of the leptin:Adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 52: 2345–2349.
    1. Lee CC, Adler AI, Sandhu MS, Sharp SJ, Forouhi NG, et al. (2009) Association of C-reactive protein with type 2 diabetes: Prospective analysis and meta-analysis. Diabetologia 52: 1040–1047.
    1. Best LG, Zhang Y, Lee ET, Yeh JL, Cowan L, et al. (2005) C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: The strong heart study. Circulation 112: 1289–1295.
    1. Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107: 363–369.
    1. Yates T, Davies MJ, Gorely T, Talbot D, Bull F, et al. (2010) The effect of increased ambulatory activity on markers of chronic low-grade inflammation: Evidence from the PREPARE programme randomized controlled trial. Diabet Med 27: 1256–1263.
    1. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53: 693–700.
    1. Kristiansen OP, Mandrup-Poulsen T (2005) Interleukin-6 and diabetes: The good, the bad, or the indifferent? Diabetes 54 Suppl 2S114–24.
    1. Heinrich PC, Castell JV, Andus T (1990) Interleukin-6 and the acute phase response. Biochem J 265: 621–636.
    1. Fischer CP, Hiscock NJ, Penkowa M, Basu S, Vessby B, et al. (2004) Supplementation with vitamins C and E inhibits the release of interleukin-6 from contracting human skeletal muscle. J Physiol 558: 633–645.
    1. Pedersen M, Steensberg A, Keller C, Osada T, Zacho M, et al. (2004) Does the aging skeletal muscle maintain its endocrine function? Exerc Immunol Rev 10: 42–55.
    1. Pedersen BK (2012) Muscular interleukin-6 and its role as an energy sensor. Med Sci Sports Exerc 44: 392–396.
    1. Hamilton MT, Hamilton DG, Zderic TW (2007) Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 56: 2655–2667.
    1. Piya MK, McTernan PG, Kumar S (2013) Adipokine inflammation and insulin resistance: The role of glucose, lipids and endotoxin. J Endocrinol 216: T1–T15.
    1. Ishii S, Karlamangla AS, Bote M, Irwin MR, Jacobs DR Jr, et al. (2012) Gender, obesity and repeated elevation of C-reactive protein: Data from the CARDIA cohort. PLoS One 7: e36062.
    1. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282: 2131–2135.
    1. Alley DE, Seeman TE, Ki Kim J, Karlamangla A, Hu P, et al. (2006) Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain Behav Immun 20: 498–504.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir